Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-07-09–present
Anthony Pierce
Board Member
Amphastar Pharmaceuticals, Inc. (AMPH)Equibles does not estimate personal net worth.
Get an email with a short summary when Amphastar Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMPH alertsAbout Anthony Pierce
Anthony Pierce is recorded as Board Member at Amphastar Pharmaceuticals, Inc. (AMPH) since July 9, 2026. Amphastar Pharmaceuticals, Inc. reported in an 8-K filed July 13, 2026 that Anthony Pierce was appointed Class III director, effective July 9, 2026. Amphastar Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amphastar Pharmaceuticals, Inc. includes Jack Yongfeng Zhang (CEO and Board Member), William J. Peters (CFO and Board Member), William Peters (CFO) and 7 others.
“On July 9, 2026, the Board of Directors (the "Board") of Amphastar Pharmaceuticals, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the "Nominating Committee"), approved an increase to the authorized number of directors permitted to serve on the Board from ten (10) to eleven (11) directors and appointed Anthony Pierce, to serve as a Class III director, to hold office until the Company's 2028 annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal, effective immediately.”
Affiliation history
-
Current
2026-07-09–present
Company network
Leadership on record at Amphastar Pharmaceuticals, Inc.
- Jack Yongfeng Zhang CEO, Board Member
- William J. Peters CFO, Board Member
- William Peters CFO
- Mary Ziping Luo COO, Board Member
- Jason B. Shandell General Counsel
- David Gaugh Board Member
- Gayle Deflin Board Member
- Howard Lee Board Member
- Jacob Liawatidewi Board Member
- Michael A. Zasloff Board Member